Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

BUBR1 Inhibitors

BUBR1 inhibitors represent a class of small molecules designed to modulate the activity of the mitotic checkpoint kinase BUBR1, a key regulator of chromosome segregation during cell division. Among the direct inhibitors, ZM447439 stands out by directly targeting the kinase activity of BUBR1, disrupting its phosphorylation of substrates and impairing the mitotic checkpoint. This leads to aberrant cell division and genomic instability, making ZM447439 a valuable tool for studying the specific functions of BUBR1 in maintaining chromosome stability during mitosis. Indirect inhibitors, such as BAY 1217389 and BAY 1816032, target the closely associated kinase BUB1, disrupting the spindle assembly checkpoint (SAC) and impacting BUBR1-mediated signaling pathways. These compounds lead to defects in chromosome segregation and mitotic progression, providing insights into the interconnected roles of BUBR1 and BUB1 in mitotic regulation. TAK-960, a potent Aurora A kinase inhibitor, indirectly influences BUBR1 by disrupting the SAC, highlighting the crosstalk between Aurora A and BUBR1 in the regulation of mitotic events. Additionally, inhibitors like Reversine, S-Trityl-L-cysteine, and Barasertib indirectly modulate BUBR1 by affecting spindle dynamics or inhibiting kinases involved in mitosis. These compounds induce mitotic arrest, activate the SAC, and lead to defective chromosome segregation. This emphasizes the importance of spindle dynamics and kinase activities in BUBR1-mediated mitotic regulation. The class of BUBR1 inhibitors also includes compounds targeting kinases like PLK1 (CCT251455, BI 2536) and Aurora A/B (NMS-P937, TAK-901). These inhibitors indirectly impact BUBR1-mediated signaling pathways, resulting in defects in chromosome segregation and mitotic progression. In conclusion, BUBR1 inhibitors, whether direct or indirect, provide valuable tools for researchers to dissect the intricate roles of BUBR1 in maintaining genomic stability during cell division. These compounds offer insights into the regulatory mechanisms of the mitotic checkpoint and contribute to our understanding of the interconnected signaling pathways governing proper chromosome segregation.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

ZM-447439

331771-20-1sc-200696
sc-200696A
1 mg
10 mg
$153.00
$356.00
15
(1)

ZM447439 is a small molecule inhibitor that directly targets BUBR1. It inhibits the kinase activity of BUBR1, preventing its phosphorylation of substrates. This direct inhibition disrupts the mitotic checkpoint, leading to aberrant cell division and genomic instability.

TAK-960

1137868-52-0sc-364631
sc-364631A
5 mg
10 mg
$316.00
$666.00
1
(1)

TAK-960 is a potent Aurora A kinase inhibitor that indirectly affects BUBR1. By inhibiting Aurora A, TAK-960 disrupts the SAC and influences BUBR1-mediated signaling pathways during mitosis.

Reversine

656820-32-5sc-203236
5 mg
$221.00
13
(1)

Reversine is a small molecule that indirectly influences BUBR1 by inhibiting Aurora B kinase. By disrupting Aurora B activity, Reversine affects the SAC and leads to altered BUBR1-mediated signaling pathways during mitosis.

S-Trityl-L-cysteine

2799-07-7sc-202799
sc-202799A
1 g
5 g
$32.00
$66.00
6
(1)

S-Trityl-L-cysteine is an inhibitor of the mitotic kinesin Eg5, indirectly affecting BUBR1 by disrupting spindle assembly. By inhibiting Eg5, S-Trityl-L-cysteine induces mitotic arrest and activates the SAC, influencing BUBR1-mediated signaling pathways.

BI 2536

755038-02-9sc-364431
sc-364431A
5 mg
50 mg
$151.00
$525.00
8
(1)

BI 2536 is a potent PLK1 inhibitor that indirectly modulates BUBR1 activity. By inhibiting PLK1, BI 2536 disrupts the SAC and influences BUBR1-mediated signaling pathways during mitosis.